This message was sent to ##Email##
|
|
|
|
|
Medical Xpress
The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004 to 2013, reports a new Northwestern Medicine study. The report considers whether a recent trend of fewer men being screened may be contributing to the rise, or whether the disease has become more aggressive — or both. The largest increase in new cases was among men 55 to 69 years old, which rose 92 percent in the past decade.
READ MORE
InformationWeek
Genomic research and precision medicine are on the leading edge of cancer research and treatment, but the huge size of the data sets and the complexity of sharing those data sets among researchers thwart progress. Here's one project that is aiming to remove those obstacles.
READ MORE
|
Promoted by
|
|
|
|
 |
Medscape
When it comes to understanding survival prognosis and treatment trade-offs near the end of life, patients with advanced cancer and their physicians do not appear to be on the same page.
A cross-sectional analysis of 236 patients and 38 oncologists shows that 68 percent of patients with incurable cancer held opinions about their survival prognosis that differed from those of their oncologist. What's more, only 1 in 10 patients knew they did not have the same understanding.
READ MORE
NPCRC
The Commission on Cancer (CoC) is dedicated to supporting cancer program efforts that reduce the burden of cancer while improving the cancer experience through palliative care. For cancer programs with onsite palliative care services, the National Palliative Care Registry™ is accepting palliative care program data for 2015. Participation in this registry is not a requirement of the CoC.
The Registry is a joint project of the Center to Advance Palliative Care (CAPC) and the National Palliative Care Research Center (NPCRC). It provides actionable data that programs can use to secure, expand and retain resources for delivery of high-quality palliative care, and to support the establishment of new palliative care programs where none exist. The Registry has recently expanded to include community-based settings, including palliative care services embedded in cancer programs.
The Registry is free and open to all. Please share this information with your palliative care program partner as a reminder to submit their 2015 data. Programs can learn more and enter data here.
READ MORE
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text.
|
|
Cure
As less toxic radiation and targeted and immunotherapies continue to advance into the realm of head and neck cancer, older patients can now receive more individualized treatment plans.
"One can speculate that we can push the boundaries of treatment," argued Sandro V. Porceddu in his presentation during an education session at the 2016 ASCO Annual Meeting focused on challenging cases in the management of head and neck cancer.
READ MORE
Medscape
A simple blood test may be able to predict the likelihood of disease recurrence in colorectal cancer, according to a new report.
The genetic test can detect circulating tumor DNA (ctDNA) after patients with stage II colon cancer undergo surgical resection, which, in turn, appears to identify many of those patients at the highest risk for recurrence.
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
AJCC
The AJCC announces five disease site webinars that are scheduled for summer and early fall this year. The webinars, offered at no cost, will provide highlights of the five most common site chapters for AJCC 7th edition staging and include: Melanoma, Lung, Breast, Colorectum and Prostate. There will be pre- and post-education quizzes to serve as a self-assessment for the information learned. The webinars will provide information on the uniqueness, differences, exceptions or special concerns for the disease sites.
Each lecture will contain the following topics:
Overview and Learning Objectives
Anatomy Affecting Stage
Classification Issues
Assigning T, N, M, Stage Group
Information and Questions on AJCC Staging and Summary
The first live webinar (Melanoma) will occur on July 27. The second webinar (Lung) will be
held Aug. 16. The webinars will be recorded for anyone who is not able to attend the live session. Register now.
You can visit the AJCC website to learn more about the Disease Site webinars and stay informed.
Press of Atlantic City
A lot of things have changed in the past year for Amy Schwartz.
Her long, curly hair is now short and blonde. Ribbons of scars decorate her chest. Medical bills are piled up at home. Chemicals still linger in her blood and tissues.
But she's alive.
Schwartz, 44, of Ocean City, survived a disease that adds to the high cancer rate in New Jersey. The state leads in the top five in the country with the highest rates of cancer overall, but experts said access to cancer treatment in New Jersey has led to more people surviving their diseases.
READ MORE
Newsweek
The U.S. Supreme Court has issued a mixed ruling in a case concerning patents held by Myriad Genetics Inc. over the closely watched issue of whether human genes can be patented.
READ MORE
|
|
Advertisement
 |
|
For the past 22 years, EduCare's mission has been to support Healthcare Professionals in educating breast cancer patients. We strive to offer products that are patient-friendly and up-to-date. Patient education increases compliance, reduces time constraints and promotes a partnership between patient and healthcare providers.
|
|
|
|
|
Advertisement
 |
|
Specialty Practice Management is a complete front- and back-office solution that offers a rapid return on your investment and improved satisfaction among your staff. Practices with 10 or fewer providers turn to this comprehensive solution to manage self-pay accounts and eliminate common mistakes.
|
|
|
|
The Cancer Support Community is interested in understanding the experiences of people accessing
cancer care in the new and evolving healthcare system. Your input will help us understand the
issues and experiences that patients have accessing cancer care, and allow us to identify the
necessary steps to ensure that the healthcare system is adequately serving people affected by
cancer. Take the survey.
Medical Xpress
Scientists at the Sanford Burnham Prebys Medical Discovery Institute have identified over 100 new genetic regions that affect the immune response to cancer. The findings, published in Cancer Immunology Research, could inform the development of future immunotherapies — treatments that enhance the immune system's ability to kill tumors.
READ MORE
ACS
Accreditation 101: Learning the Basics of CoC Accreditation and Standards will be held Sept. 9 in Chicago. This one-day program, taught by CoC surveyors and staff, provides an overview of the CoC accreditation standards and answers your questions about the standards and the survey process. This is the last time this program will be held in 2016.
California Healthline
California is overhauling the way it collects information for its massive cancer database in the hope of improving how patients are treated for the disease.
Pathologists at a dozen hospitals in the state are part of a pilot project — the first of its kind in the United States — in which they are reporting cancer diagnoses in close to real-time to the California Cancer Registry. And they are using standardized electronic forms to make their reporting more consistent and accurate.
That represents a significant change for the registry, which traditionally relies on data up to two years old.
READ MORE
Medical News Today
Many cancer deaths occur because cancer cells develop resistance to chemotherapy drugs, prompting a field of research bent on overcoming this treatment barrier. An important step forward took place recently when researchers showed a newly discovered class of molecules can kill mouse cancer cells that have become multi-drug resistant.
READ MORE
Cure
Fatigue is one of the most common side effects of cancer treatment that can persist long after treatment ends, but a new study has found that acupressure, a derivative of traditional Chinese medicine that puts pressure on Qi points using thumbs or devices, may provide women with some much-needed relief. Researchers found that the technique reduced fatigue by 27 percent to 34 percent over six weeks. In addition, two-thirds of women in the study who performed relaxing acupressure reported having normal fatigue levels.
READ MORE
For additional information, please complete the mailing list request form.
|
|
|
Advertisement
Advertisement
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
